Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women and is associated with subfertility and adverse perinatal outcomes, which may include early pregnancy loss, gestational diabetes mellitus, hypertensive spectrum disorder, preterm birth, fetal growth disorders, and cesarean deliveries. The phenotypic heterogeneity, different diagnostic criteria, and PCOS-related conditions that women enter pregnancy with have limited evidenced-based studies and guidelines to reduce pregnancy complications among this high-risk population. This review summarizes the available evidence on the approach and management of women with PCOS preconception, prenatal, and postpartum.
Original language | English (US) |
---|---|
Pages (from-to) | 57-69 |
Number of pages | 13 |
Journal | Endocrinology and Metabolism Clinics of North America |
Volume | 50 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2021 |
Keywords
- Metformin
- Perinatal management
- Polycystic ovary syndrome
- Pregnancy complications
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology